Sodium Bicarbonate Ringer's Solution for Preventing and Treating Hyperlactacidemia During Hepatectomy

Sponsor
First Affiliated Hospital Xi'an Jiaotong University (Other)
Overall Status
Recruiting
CT.gov ID
NCT04547296
Collaborator
Henan Provincial People's Hospital (Other), Henan Cancer Hospital (Other), LanZhou University (Other), Affiliated Hospital of Qinghai University (Other), Shaanxi Provincial People's Hospital (Other), First Affiliated Hospital of Xinjiang Medical University (Other), People's Hospital of Xinjiang Uygur Autonomous Region (Other)
484
7
2
23
69.1
3

Study Details

Study Description

Brief Summary

A variety of reasons lead to a sharp increase in lactic acid levels in patients undergoing liver resection, while leading to hyperlactic acidemia, resulting in decreased cardiac output, elevated blood potassium, and response to catecholamines and insulin Damage, increased risk of kidney damage, poor recovery of liver function, decreased immune function, and prolonged hospital stay. Sodium bicarbonate Ringer injection does not contain lactic acid. HCO3- is metabolized by acid-base neutralization in body fluids, and 90% is CO2 The form is excreted from the body by breathing, and only 10% HCO3- is metabolized by the kidney, without the burden of liver metabolism. Physiological concentration of Cl- avoids perchloric acidosis and kidney damage; physiological concentration of Ca2+ and Mg2+ help maintain the body's electrolyte balance and reduce stress-related arrhythmia.The smooth development of this study will help refine the intraoperative fluid management strategy, improve the patient's intraoperative tissue perfusion, maintain the body's acid-base and electrolyte balance, reduce postoperative kidney damage, and improve the patient's quality of life.

Condition or Disease Intervention/Treatment Phase
  • Drug: Sodium Bicarbonate Ringer's Solution
N/A

Detailed Description

This study intends to carry out a high-quality clinical research with design specifications, large sample, multi-center, randomized and controlled methods. From October 9, 2020 to October 9, 2022, participants undergoing hepatectomy surgery under general anesthesia will be recruited. Participants will be randomly assigned, in a 1:1 ratio, to receive Sodium bicarbonate Ringer's solution or control (Acetate Ringer's solution). The randomization sequence will be computer-generated, and randomization will be performed in blocks and will be stratified according to participating center. After entering the operating room, the two groups were pre-dilated with sodium bicarbonate Ringer or acetate Ringer (30 min, 8 ml/kg). After the operation started, the two groups of participants were maintained with 4-5 ml/kg/h Ringer's solution during the operation. Blood gas index (but are not limited to these data) at intraoperative will be recorded. At the same time, other dates will be recorded.The participation of each patient is scheduled for 1 month.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
484 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Sodium Bicarbonate Ringer's Solution for Preventing and Treating Hyperlactacidemia During Hepatectomy: a Multicenter, Randomized and Controlled Study
Actual Study Start Date :
Apr 28, 2021
Anticipated Primary Completion Date :
Oct 9, 2022
Anticipated Study Completion Date :
Mar 30, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: BRS group

After entering the operating room, this group were pre-dilated with sodium bicarbonate ringer's solution (30 min, 8 ml/kg), and maintained with 4-5 ml/kg/h sodium bicarbonate ringer's solution during the operation.

Drug: Sodium Bicarbonate Ringer's Solution
After the participants enter the operating room, radial artery puncture and catheterization were performed. The blood gas in the non-oxygen state was used as the basic value. A peripheral venous access was established in one upper limb, and the two groups were pre-dilated with sodium bicarbonate Ringer's solution or acetate Ringer's solution (30 min, 8 ml/kg). For laparoscopic surgery, adjust the PaCO2 value to 35-45 mmHg again 10 minutes after the establishment of the pneumoperitoneum. After the operation started, the two groups of participants were maintained with 4-5 ml/kg/h Ringer's solution during the operation. Blood gas was measured every hour after tracheal intubation during the operation, and the last blood gas was measured when the skin was sutured. When the blood gas pH <7.2, 5% sodium bicarbonate injection was given to correct it.
Other Names:
  • Acetate Ringer's Solution
  • Experimental: ARS group

    After entering the operating room, this group were pre-dilated with acetate ringer ringer's solution (30 min, 8 ml/kg), and maintained with 4-5 ml/kg/h acetate ringer's solution during the operation.

    Drug: Sodium Bicarbonate Ringer's Solution
    After the participants enter the operating room, radial artery puncture and catheterization were performed. The blood gas in the non-oxygen state was used as the basic value. A peripheral venous access was established in one upper limb, and the two groups were pre-dilated with sodium bicarbonate Ringer's solution or acetate Ringer's solution (30 min, 8 ml/kg). For laparoscopic surgery, adjust the PaCO2 value to 35-45 mmHg again 10 minutes after the establishment of the pneumoperitoneum. After the operation started, the two groups of participants were maintained with 4-5 ml/kg/h Ringer's solution during the operation. Blood gas was measured every hour after tracheal intubation during the operation, and the last blood gas was measured when the skin was sutured. When the blood gas pH <7.2, 5% sodium bicarbonate injection was given to correct it.
    Other Names:
  • Acetate Ringer's Solution
  • Outcome Measures

    Primary Outcome Measures

    1. Incidence of intraoperative hyperlactacidemia [During the operation]

      Diagnostic criteria: Lac ≥ 2 mmol/L, pH ≤ 7.35, HCO3- ≤ 20 mmol/L, PaCO2 <50 mmHg

    Secondary Outcome Measures

    1. The incidence of blood gas index disorder [During the operation]

      Blood gas was monitored every hour during the operation and the incidence of intraoperative blood gas index disorder was recorded

    2. Incidence of postoperative acute kidney injury [Day 2 after the operation]

      The incidence of acute kidney injury within 48h after surgery was recorded

    3. Rate of postoperative complications [Day 30 after the operation]

      postoperative complications: cardiovascular complications; pulmonary complications; infection complications; other complications

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    1. Patients for selective liver surgery under general anesthesia

    2. Age > 18 year,BMI 18 - 40 kg/m2,American society of Anesthesiologists (ASA) grade are between I - III

    3. Ability to understand, sign informed consent and cooperate with the intervention and evaluation

    Exclusion Criteria:
    1. Abnormal renal function:blood creatinine (Cr) and / or urea nitrogen (BUN)> upper limit of normal value; Patients with underlying kidney disease; patients with congenital kidney malformations.

    2. In patients with respiratory failure, arterial blood oxygen partial pressure (PaO2) < 60 mmHg, or accompanied by carbon dioxide partial pressure (PaCO2)> 50mmHg; blood oxygen saturation (SpO2) < 90%.

    3. A history of myocardial infarction within 6 months before the screening period; history of severe circulatory or respiratory diseases; history of autoimmune diseases; patients with mental illness or neurological disorders that cannot be expressed exactly; patients with a history of epilepsy; patients with pulmonary edema or congestive heart failure.

    4. Severe hypercalcemia (Ca2+ > 2.75 mmol/L), hypernatremia (Na+ > 155 mmol/L), hyperkalemia (K+ > 5.5 mmol/L), hyperchloremia (Cl- > 110 mmol/L), Hypermagnesium (Mg2+ > 1.25 mmol/L).

    5. Patients with a history of hypothyroidism; pregnant or lactating women.

    6. Patients with a history of adverse blood transfusion reactions; those who refuse blood transfusions.

    7. Participation in other clinical studies within 3 months before admission to this study.

    8. The investigator considers it unsuitable for inclusion.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 The First Hospital of Lanzhou University Lanzhou Gansu China 0931730000
    2 Henan Cancer Hospital Zhengzhou Henan China 0371450003
    3 Henan Provincial People's Hospital Zhengzhou Henan China 0371450008
    4 Qinghai University Affiliated Hospita Xining Qinghai China 0971810001
    5 Shaanxi Provincial People's Hospital Xi'an Shaanxi China 029710068
    6 People's Hospital of Xinjiang Uygur Autonomous Region Ürümqi Xinjiang China 0991830001
    7 The First Affiliated Hospital of Xinjiang Medical University Ürümqi Xinjiang China 0991830054

    Sponsors and Collaborators

    • First Affiliated Hospital Xi'an Jiaotong University
    • Henan Provincial People's Hospital
    • Henan Cancer Hospital
    • LanZhou University
    • Affiliated Hospital of Qinghai University
    • Shaanxi Provincial People's Hospital
    • First Affiliated Hospital of Xinjiang Medical University
    • People's Hospital of Xinjiang Uygur Autonomous Region

    Investigators

    • Study Chair: Qiang Wang, PHD, First Affiliated Hospital Xi'an Jiaotong University

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    First Affiliated Hospital Xi'an Jiaotong University
    ClinicalTrials.gov Identifier:
    NCT04547296
    Other Study ID Numbers:
    • XJTU1AF2020LSK-071
    First Posted:
    Sep 14, 2020
    Last Update Posted:
    Aug 19, 2021
    Last Verified:
    Aug 1, 2021
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by First Affiliated Hospital Xi'an Jiaotong University
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Aug 19, 2021